MedTrace Logo

Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

NCT06935071 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-04-16

No results posted yet for this study

Summary

This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.

Conditions

  • Hip Fractures
  • Hip Fracture Pathologic
  • Pathological Fracture
  • Pathological Fracture of Hip

Interventions

OTHER

Data Collection and Analysis

Patient data will be analyzed to ensure that all data fields are available and that suitable sample size is available to answer the research objectives. The rate of ambulation at discharge, ambulation at 3 month follow up (if available), time to death, and pain score between the historic cohort with a current cohort of patients will be compared.

Sponsors & Collaborators

Principal Investigators

  • John Healey, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-04
Primary Completion
2026-08-04
Completion
2026-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06935071 on ClinicalTrials.gov